Long after the visible battles of cancer treatment end, millions of survivors face a quieter struggle in the dark — persistent insomnia that erodes recovery, mood, and quality of life, yet goes largely untreated. Dr. Sheila Garland, a psychologist and oncology researcher at Memorial University, has spent a decade confronting this gap, and her answer is iCANSleep, a free smartphone app that brings evidence-based cognitive behavioural therapy directly to survivors who cannot reach specialists. Her work has now earned her the William E. Rawls Prize from the Canadian Cancer Society — a recognition
Education News Canada
· Jul 08, 2026
· health
· 2 min read
High
Sourcing: Verified
Memorial University researcher wins national prize for cancer sleep treatment innovation
Millions of cancer survivors experience persistent sleep disturbances that impair recovery, mood, cognition, and quality of life, with treatment access severely limited.
◉
Health & Medicine
8525 related articles
FDA Approves Pancreatic Cancer Drug That May Extend Patient Survival
CBS News · 100% match
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight Loss Drug
ScienceAlert · 99% match
Eli Lilly's Oral GLP-1 Pill Shows Promise for Diabetes and Weight Loss
TODAY · 99% match
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight-Loss Treatment
Interesting Engineering · 99% match
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 99% match
Related Coverage
BBC News · Aug 27
Facebook horse seller ordered to pay damages after selling unfit animals to buyers
Five women report being mis-sold unsafe or injured horses by a Facebook seller, with one buyer's daughter suffering a se…
Al Jazeera · Aug 27 Pakistan hospital fire kills 14 infants; families demand accountabilityFourteen babies died in a fire at Islamabad's Institute of Medical Sciences. Grieving families accuse hospital staff and…
Peter Attia MD · Aug 27 GLP-1 drugs show promise beyond metabolism, but questions remain about whyGLP-1 medications, originally developed for type 2 diabetes, now show potential benefits across metabolic and non-metabo…
Korea JoongAng Daily · Aug 27 Korean researchers identify Erbb4 protein as potential Alzheimer's breakthroughKorean researchers identified the Erbb4 protein as a key driver of Alzheimer's progression, showing it triggers synapse …
Bias & Framing
⚖
Article presents a positive profile of cancer research innovation with minimal critical examination, using affirming language throughout without counterbalancing perspectives.
Bias Direction
center-left
Confidence
MED
Achievement/progress narrative framing that emphasizes innovation solving an underaddressed problem. The article frames the researcher and app as solutions to a gap in care, using problem-solution structure that naturally favors the featured work.
overlooked aspects
struggle
closing that gap
reaching survivors
evidence-based treatments remain largely inaccessible
outstanding contributions
Skeptical or critical views on digital mental health interventions for cancer patients
Perspectives from competing researchers or alternative treatment approaches
Potential limitations or challenges of app-based therapy delivery
Cost-benefit analysis or implementation barriers not mentioned
Patient testimonials showing mixed or negative experiences (if any exist)
Healthcare provider perspectives on app integration into standard care
Geopolitical Impact
🌎
Canadian researcher develops digital health innovation for cancer survivors; primarily domestic healthcare advancement with potential for international adoption in telemedicine.
Escalation Risk
low
Confidence
LOW
Economic Lens
📈
Memorial University researcher develops iCANSleep app delivering digital cognitive behavioral therapy for cancer-related insomnia, addressing a significant healthcare access gap affecting 60% of cancer survivors.
Market Signal
bullish
Confidence
MED
Healthcare/Oncology
Digital Health/Health Tech
Pharmaceutical/Therapeutics
Mental Health Services
Medical Device/Software
Cancer survivors gain access to evidence-based insomnia treatment previously unavailable due to specialist shortages and geographic barriers. Reduces healthcare costs for patients in rural/remote areas and immunocompromised individuals unable to travel. Improves quality of life and recovery outcomes for 60% of cancer patients experiencing sleep disturbances.
Potential for digital health policy expansion and reimbursement coverage for app-based cognitive behavioral therapy. May influence cancer care guidelines to prioritize sleep management. Could drive investment in digital therapeutics regulation and integration into provincial healthcare systems. May prompt discussion of specialist shortage solutions and rural healthcare access initiatives.